调节前运动皮层兴奋度减轻了帕金森病小鼠模型中的行为和电生理异常
In Sun Choi1, Jinmo Kim2, Joon Ho Choi3
1Laboratory of Neurophysiology, Sensory and Motor Neuroscience Group, Korea Brain Research Institute, Daegu 41602, Republic of Korea; Brain Engineering Convergence Research Center, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu 42988, Republic of Korea.
Progress in neurobiology
|April 21, 2025
概括
高频刺激亚thalamic核 (STN) 投射前运动神经元通过正常化M2神经元刺激性来改善帕金森病的运动症状. 这表明M2-STN突触是帕金森病治疗的关键标.
科学领域:
- 神经科学是一个神经科学.
- 神经生物学 神经生物学 神经生物学
- 运动障碍 运动障碍
背景情况:
- 甲状腺下核 (STN) 对于抑制不必要的行为至关重要.
- 高频深度大脑刺激 (DBS) 的STN治疗帕金森病 (PD) 运动症状,但机制尚不清楚.
- 发射STN的前运动神经元 (M2) 与运动控制和PD病理生理学有关.
研究的目的:
- 在PD小鼠模型中研究STN投射M2神经元的作用.
- 探索针对STN (DBS-STN) 的深度大脑刺激对M2神经元活动和运动功能的影响.
主要方法:
- 在PD小鼠模型中检查了M2神经元发射模式和振荡.
- 应用高频刺激到STN投射的M2神经元.
- 研究过极化激活的向内电流 (Ih) 以及通过刺激和药理剂的调制 (ZD7288).
主要成果:
- 在PD模型小鼠中,M2神经元的突发发射和同步振荡增强.
- 高频刺激M2神经元,模仿DBS-STN,减少运动症状和M2过度兴奋.
- 这种治疗效果与正常化的IH和减少的发射频率有关,由ZD7288.8逆转.
结论:
- 过度的M2神经元刺激性和M2-STN突触抑制有助于PD模型中的运动缺陷.
- 通过DBS-STN激活M2神经元,通过减少M2过度兴奋来缓解运动障碍.
- M2-STN突触代表了改善帕金森病运动控制的潜在治疗点.
相关概念视频
01:37Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
01:24Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
01:15Parkinson's Disease: Overview
310
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
310